Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds
Valentina Benedetti(Mario Negri Institute for Pharmacological Research), Franco Zunino(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 54
Related Papers
Cellular Effects and Antitumor Activity of RET Inhibitor RPI-1 on MEN2A-Associated Medullary Thyroid Carcinoma
|JNCI Journal of the National Cancer Institute|2004|112
RETRACTED: Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo
|PLoS ONE|2011|62
Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid
|Cell Death and Differentiation|2003|54
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
|EBioMedicine|2018|33